Vancouver, British Columbia, Nov. 10, 2020 – iData Research, a global consulting and market research firm, just published new research in the interventional cardiology devices market, highlighting the negative impact of COVID-19 in 2020 and beyond. The recent publication provides extensive insights into the $3.2 Billion U.S. market for interventional cardiology devices, based on volume and historical trends of procedures performed in the U.S..
According to iData’s U.S. Interventional Cardiology Device Market Report, the number of cardiovascular procedures performed in the U.S., topping 970 thousand in 2019, has sharply declined in 2020 due to the postponement or cancellation of elective surgeries. The procedure analysis in the report also compares trends among angiography, angioplasty (or PCI) and coronary atherectomy procedures. Across the U.S., hospitals saw a decline in cardiovascular surgeries performed. For example, the largest U.S. for-profit hospital operator, HCA Healthcare Inc, said it had seen a 70% decline in outpatient surgeries in April 2020 compared with the year before, while inpatient admissions declined 30%.
According to Sean Collins, iData Research’s Strategic Analyst Manager, “The impact of the COVID19 pandemic on PCI [Percutaneous Coronary Intervention], the main procedure driving the IC market, was similar to other cardio markets – decline bottomed out in April/May and rebounded starting in June.”
Among the many competitors affected by this in the U.S. market, Boston Scientific, Abbott and Medtronic are the leaders by varying market shares, followed by Terumo and Philips. Over 40 other competitors which have one or more products offered in this space were analysed in the report.
To accurately estimate market shares, units sold, average selling prices, product segments and brands as well as procedural volumes, iData Research uses its proprietary databases and hospital purchase order data to complement its primary and secondary research initiatives.
Follow the link below to request a Free Research Summary of the U.S. Market Report for Interventional Cardiology Devices: